Urgent.News

What's breaking now, across thousands of outlets.

Business

Lotte Biologics Wins First Major Commercial Production Deal for Songdo Plant 1

Lotte Biologics has secured its first major commercial production contract for Plant 1 at its Songdo Bio Campus in Incheon, positioning itself as a key player in the global contract development and manufacturing organization (CDMO) market. The company has signed a contract with a global pharmaceutical company for the production of key products, including active pharmaceutical ingredients (APIs) and finished drug products, with full-scale operations targeted for 2027.

The undisclosed contract value and specific terms indicate the significance of this deal, as it provides a basis for the company to ramp up utilization as the facility begins operations.

Brief written by urgent.news from BusinessKorea's own syndicated text. Machine-written — may contain errors; check the original before relying on it.

Read the original at businesskorea.co.kr →

More in Business

More from Tuesday 17 November →